Therapeutic agents regulate phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway or autophagy for glioblastoma (GB) treatment. This evidence concerns the gene PIK3CD and glioblastoma.